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Hypothalamic adrenoceptors mediate sympathoadrenal 
activity in exercising rats 
ANTON J. W. SCHEURINK, ANTON B. STEFFENS, AND RON P. A. GAYKEMA 
Department of Animal Physiology, State University of Groningen, 9750 AA Haren, The Netherlands 
SCHEURINK, ANTON J. W., ANTON B. STEFFENS, AND RON 
P. A. GAYKEMA. Hypothalamic adrenoceptors mediate syrnpa- 
thoadrenal activity in exercising rats. Am. J. Physiol. 259 (Reg- 
ulatory Integrative Comp. Physiol. 28): R470-R477, 1990.- 
The role of hypothalamic adrenoceptors in the exercise-induced 
alterations of plasma norepinephrine (NE), epinephrine (E), 
and corticosterone concentrations was investigated in rats. 
Exercise consisted of strenuous swimming against a counter- 
current for 15 min. Before, during, and after swimming, blood 
samples were withdrawn through a permanent heart catheter 
for determination of E, NE, and corticosterone. In control rats 
E, NE, and corticosterone levels were all increased during 
exercise. Infusion of the ar-adrenoceptor antagonist phentola- 
mine through permanent bilateral cannulas into the ventro- 
medial hypothalamus (VMH) immediately before exercise re- 
duced the exercise-induced increase in plasma E without af- 
fecting NE. Infusion of the ,&adrenoceptor antagonist timolol 
into the VMH enhanced plasma E and attenuated plasma NE 
increases. Infusion of phentolamine into the lateral hypothal- 
amic area (LHA) led to enhanced NE and unchanged E con- 
centrations, whereas infusion of timolol into the LHA caused 
a potentiation of the increase in plasma E without an effect on 
NE. Plasma corticosterone concentrations were not affected. 
The results suggest that 1) cy- and ,8-adrenoceptors in the 
hypothalamus influence peripheral catecholamine release, and 
2) E and NE responses to exercise can be dissociated by 
interference of the central nervous system. 
ventromedial hypothalamus; lateral hypothalamic area; cu-adre- 
noceptor; ,&adrenoceptor; epinephrine; norepinephrine; corti- 
costerone; exercise 
IT IS WELL ESTABLISHED that peripheral energy metab- 
olism is regulated by the central nervous system, in 
particular by catecholamine-sensitive neurons within the 
ventromedial and lateral areas of the hypothalamus 
(VMH and LHA, respectively) (24, 27, 30). Recently, 
evidence was obtained for a substantial role of adre- 
noceptors in the VMH and LHA in the regulation of 
plasma glucose and free fatty acids (FFA) concentrations 
in exercising rats (19). Since exercise is attended with 
substantial hormonal and metabolic adaptations to in- 
crease the supply of energy substrates like glucose and 
FFA to the working muscle (5, 20, 21, 36), these results 
confirm the view that interference of the central nervous 
system in peripheral metabolic functions is of particular 
interest in situations deviating from the normal basal 
conditions such as malnutrition (28) and hypoglycemia 
(1) 
The pathways by which the hypothalamus may regu- 
late peripheral glucose and FFA release during exercise 
are still unknown. Both autonomic neural connections 
and neuroendocrine circuits may be involved (9). Acti- 
vation of the sympathoadrenal system, reflected by in- 
creased plasma levels of norepinephrine (NE) and epi- 
nephrine (E), causes changes in glucose and FFA metab- 
olism during exercise (5, 20, 22). Recent studies in 
anesthetized rats (7, 39) and resting cats (17, 31, 32) 
showed that either lesions or electrical and chemical 
stimulation of the hypothalamus may change plasma 
levels of NE and/or E. These data suggest that hypothal- 
amic regulation of energy metabolism during exercise 
may be achieved via influences on the activation of the 
sympathoadrenal system. More precisely, CY- and ,&adre- 
noceptors in the VMH and LHA might be involved in 
the regulation of plasma E and NE concentrations during 
exercise. In the present study cy- and ,&adrenoceptor 
antagonists were locally infused into the VMH or LHA 
of swimming rats to investigate the role of the catechol- 
amine-sensitive neurons in the hypothalamus on plasma 
E and NE levels during exercise. Plasma corticosterone 
concentrations were also measured because recent stud- 
ies suggested that hypothalamic adrenoceptors may play 
a role in the activation of the hypothalamic-adrenocor- 
ticotropic axis (15, 33), an alternative pathway by which 
the hypothalamus can influence blood glucose and FFA 
concentrations. 
MATERIALS AND METHODS 
Animals and housing. Male Wistar rats weighing 300- 
350 g at the beginning of the experiments were used. 
They were housed individually in Plexiglas cages (25 X 
25 x 30 cm) at room temperature (20 t 2°C) and had 
continuous access to food (Muracon lab chow) and water 
unless otherwise stated. The rats were maintained on a 
12:12 h light-dark cycle (0700-1900 h light) and were 
handled and weighed every day at 0900 h. 
Surgery. All surgery was performed under ethyl ether 
anesthesia. One week of recovery was allowed between 
subsequent surgeries. The experiments started as soon 
as the rat returned to preoperative body weight. 
Implantation of brain cannulas. Bilateral permanent 
stainless steel cannulas (in mm: 21.0 length, 0.3 OD, 0.1 
ID) for drug infusion were stereotactically implanted into 
either the LHA (in mm: anteroposterior (AP)6.0, ventral 
(V)l.S, lateral (L)f1.7) or the VMH (in mm: AP6.2, 
V0.9, L&0.7) according to the coordinates of Paxinos and 
Watson (13). A sterile stainless steel obturator, flushed 
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with the tip of the cannula, was inserted into each 
cannula between experiments to ensure that the cannula 
remained patent and pyrogen free. The cannula end 
protruding from the skull was protected with a Zl-gauge 
protective sleeve, except for the last 4 mm at the top of 
the cannula. The protective sleeve was affixed onto the 
skull with acrylic. A piece of polyethylene tubing was put 
around the cannula and obturator. A polyethylene cap 
was placed at the protruding end of the protective sleeve 
to cover the free end of the cannula. 
Implantation of heart catheters. All animals were pro- 
vided with a silicon heart catheter through the jugular 
vein externalized on the top of the skull according to the 
techniques described earlier (25). This method allows 
frequent repeated blood sampling in unanesthetized, un- 
disturbed freely moving rats (26, 38). 
Blood-sampling procedure and chemical determina- 
tions. Forty minutes before the start of an experiment 
the animals were connected with a polyethylene blood- 
sampling tube (in mm: 400 length, 1.25 OD, and 0.75 ID) 
through which blood was sampled as described earlier 
(26). During the whole experiment 14 blood samples of 
0.4 ml were withdrawn for determination of plasma cate- 
cholamine and corticosterone concentrations. After each 
sample a transfusion of 0.4 ml of titrated donor blood 
was given to avoid diminution of the blood volume with 
related changes in hemodynamics. Donor blood was ob- 
tained from undisturbed rats with permanent heart cath- 
eters. Between the withdrawal of blood samples, the tip 
of the heart catheter was filled with 6% citrate solution 
as an anticoagulant. Citrate was used to avoid activation 
of endothelial lipase. 
Blood samples were immediately transferred to chilled 
(0°C) centrifuge tubes containing 0.01% EDTA as an 
antioxidant and 10 ~1 heparin solution (500 U/ml) as an 
anticoagulant. Blood was centrifuged for 15 min at 5,000 
revolutions/min and 4”C, and 100 ~1 of the supernatant 
were immediately stored at -80°C for the catecholamine 
measurements. The remaining plasma was stored at 
-30°C for the corticosterone assay. Determination of 
plasma catecholamine concentrations was performed by 
high-pressure liquid chromatography in combination 
with electrochemical detection (HPLC-ECD) as previ- 
ously described (16) with minor modifications. The 
HPLC-ECD system included an LKB 2150 pump (LKB 
Instruments, Bromma, Sweden), a Rheodyne injection 
valve with a 50-~1 loop, two reversed-phase chromsphere 
Cl8 cartridge columns in conjunction (Chrompack, The 
Netherlands) held at 30°C by a column stove (LKB), an 
ESA 5100 A electrochemical detector with a 5011 high 
sensitive analytical cell and a 5020 guard cell (ESA, Kipp, 
The Netherlands), and a BD 41 two-channel flat recorder 
(Kipp). Guard cell potential in front of the injection 
valve was +450 mV, and the potentials of the working 
electrodes were -50 and +350 mV, respectively. The 
mobile phase contained 0.05 M sodium acetate, 0.08% l- 
heptanesulfonic acid, 0.01% EDTA, 0.01% NaCl, and 5% 
methanol-95% H20 (pH 4.75). Absolute detection levels 
for E and NE in plasma were 0.010 and 0.005 rig/ml, 
respectively. 
Corticosterone was extracted from 30 ~1 plasma via 
solid-phase extraction with acetonitrile on a Baker SPE 
Cls l-ml column (Baker, The Netherlands). Quantifica- 
tion of plasma corticosterone was performed by high- 
pressure liquid chromatography in combination with ul- 
traviolet detection (HPLC-UVD). The HPLC-UVD sys- 
tem included an LKB 2150 pump (LKB), a Rheodyne 
injection valve with a 50-~1 loop, a reverse-phase chrom- 
sphere Cs column (Chrompack), a Spectroflow 757 UV 
detector (254 nm) (Spectroflow, The Netherlands), and 
a BD 41 flat recorder (Kipp). The mobile phase contained 
1.05% citric acid monohydrate (reagent grade), 1.86% 
Na2HP04. 12H20, 38% methanol, and 3.8% methylene 
chloride (HPLC grade, Rathburn), pH 3.3. Absolute de- 
tection limit for corticosterone in plasma was 1 pg/lOO 
ml. 
VMH and LHA infusion procedure. After removal of 
the cap and obturator, a sterile polyethylene tubing (in 
mm: 400 length, 0.61 OD, and 0.20 ID) was attached to 
each brain cannula 40 min before the start of an experi- 
ment. The tubing had previously been filled with sterile 
test fluid except for the last 8 mm at the distal end, 
which remained filled with air. This end was sealed off 
at 4 mm. Thus any unwanted leakage of test fluid into 
the brain before the beginning of the infusion was pre- 
vented. An air bubble (4 mm length) remained under the 
sealed end. The distal end of each infusion tubing re- 
mained outside the animal’s cage so as not to disturb the 
animal. At the start of the infusion, the sealed ends of 
the tubes were cut off and the tubing was immediately 
connected to the infusion pump. The onset of moving of 
the air bubble was designated as the start of the infusion. 
Constant movement of the air bubble verified that a 
continuous infusion occurred. At the end of the 20-min 
infusion, the distal end of the tubing was disconnected 
from the infusion pump and immediately sealed off. 
Adrenoceptor antagonists. The CY- and @-adrenoceptor 
antagonists phentolamine and timolol were infused into 
the VMH and LHA. The drugs were dissolved in sterile 
artificial cerebrospinal fluid (aCSF) containing (in mM) 
127.64 NaCl, 2.55 KCl, 1.26 CaClz, and 0.93 MgC12*6Hz0. 
Phentolamine (.Regitine, Ciba Geigy) was infused at a 
rate of 1.05 pg in 0.25 ~1 aCSF/min for 20 min. Timolol 
(Merck Sharp & Dohme) was infused at a rate of 0.7 pg 
in 0.25 ~1 aCSF/min for 20 min. These doses appeared 
to result in an effective blockade of hypothalamic cy- and 
,&adrenoceptors (19). Timolol (instead of propranolol) 
was used because the hydrophylic character of timolol 
would better prevent leakage of the drug through the 
blood-brain barrier. 
Exercise. Exercise was performed in a pool made of 
stainless steel (3.00 x 0.40 x 0.90 m) and filled 70% with 
water at 33 t 2OC. At one end the pool was equipped 
with a starting platform (33 x 37 cm), placed -2 cm 
above the water level. This starting platform could be 
lowered into the water to the bottom of the swimming 
pool. A water pump (Loewe Silenta, FRG) caused a 
strong countercurrent of 0.22 m/s, which forced the 
animal to swim continuously. At the end of the exercise 
period, a removable resting platform (20 x 37 cm) at the 
upstream side of the swimming pool was offered to the 
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this lightened and warmed platform within 2 min after 
it was offered. To eliminate an emotional stress compo- 
nent, the rats were accustomed to the experimental con- 
ditions by subjecting them to swimming several times 
before the onset of the actual experiments. 
Experimental procedure. All experiments were per- 
formed in the light period between 1000 and 1300 h. On 
the experimental day food was removed 1.5 h before the 
start of the experiment. To measure the basal levels of 
the blood components, two blood samples in a lo-min 
interval were taken in the home cage of the rat. Subse- 
quently, the rat was placed for 30 min on the starting 
platform in the swimming pool. Blood samples were 
taken after 10, 20, and 30 min. The infusion of the 
adrenoceptor antagonists phentolamine and timolol or 
aCSF into the VMH or LHA was performed in the period 
on the starting platform between time (t) = 10 and 30 
min. Immediately after the infusion and the last blood 
sampling, the starting platform was slowly lowered to 
the bottom of the swimming pool. This lasted for -5 
min, and after 2 min one blood sample was taken. The 
time point at which the rat started to swim was consid- 
ered t = 0 min. The animal had to swim against the 
countercurrent for 15 min. Blood samples were taken at 
t= 1, 5, 10, and 15 min during exercise. At the end of 
the exercise period the resting platform was lowered. 
During the resting period postexercise blood samples 
were taken at t = 19, 24, 29, and 39 min after the start 
of exercise. Plasma catecholamine concentrations were 
determined in all blood samples. Plasma corticosterone 
levels were measured in the blood samples taken at -1 
min in the home cage, at t = 10 and 30 min on the 
starting platform, and at t = 5,15, 24, and 39 min during 
and after exercise. 
Histology. At the termination of the experiments, brain 
cannula placement was determined as follows. The rat 
was anesthetized with ether and perfused through the 
heart with 10% Formalin. The brain was removed and 
stored for 1 wk in 10% Formalin. After one night storage 
in 10% Formalin and 30% sucrose, the brain was quickly 
frozen in melting isopentane (-SOOC) and cut at 40 pm 
on a cryostat microtome (-20°C). Brain slices were 
stained with cresyl fast violet, examined under a light 
microscope, and identification of the site was carried out 
TABLE 1. Basal values of norepinephrine, epinephrine, 
and corticosterone in plasma 
Plasma Plasma Plasma 
NE, E, Corticosterone, 
rig/ml w/ml pg/lOO ml 
VMH 
aCSF (n = 7) 0.36t0.095 0.07t0.014 13.7t5.2 
Phentolamine (n = 6) 0.20t0.033 0.09t0.016 13.9t5.8 
Timolol (n = 7) 0.26t0.040 0.07t0.016 11.2t4.1 
LHA 
aCSF (~2 = 5) 0.26t0.033 0.13t0.123 22.0t6.2 
Phentolamine (n = 6) 0.25kO.011 0.11t0.035 17.9t4.4 
Timolol (n = 6) 0.22t0.016 0.08kO.024 28.0t4.5 
Values are averages t SE of plasma norepinephrine (NE), epineph- 
rine (E), and corticosterone as measured at time = -1 min in home 
cage before rat was placed on starting platform in swimming pool. n, 
no. of rats. VMH, ventromedial hypothalamus; LHA, lateral hypothal- 
amic area; aCSF, artificial cerebrospinal fluid. 
by comparison with the atlas of Pellegrino et al. (14). All 
experimental rats showed correct cannula placement in 
the VMH or LHA. 
Experiments and statistics. The effects of hypothal- 
amic infusion of cy- and P-adrenoceptor antagonists on 
plasma E, NE, and corticosterone were investigated in 
exercising rats. Two different groups of rats with can- 
nulas aimed in either the VMH (n = 7) or LHA (n = 6) 
were used. Only data from experiments in which fluid 
infusion into either VMH or LHA was unimpeded were 
included in the study. Infusion of the a-adrenoceptor 
antagonist phentolamine at a rate of 1.05 pg in 0.25 ~1 
aCSF/min for 20 min was performed in experiment la 
(infusion into the VMH) and experiment Ib (infusion 
into the LHA). Infusion of the P-adrenoceptor antagonist 





























0 20 0 15 min 
FIG. 1. Effect of infusion of cu-adrenoceptor antagonist phentola- 
mine [phentol; 1.05 pg in 0.25 ~1 artificial cerebrospinal fluid (CSF)/ 
min for 20 min] into ventromedial hypothalamus (VMH) on plasma 
norepinephrine (NE) and epinephrine (E) concentrations before, dur- 
ing, and after exercise. Control experiment consisted of an infusion of 
artificial CSF into VMH at a rate of 0.25 pl/min for 20 min. Data for 
NE and E are expressed as average changes t SE from basal home- 
cage levels. Swimming period is indicated by dotted area, and period in 
which drug was administered is indicated with a horizontal solid line 























FIG. 2. Effect of infusion of P-adrenoceptor antagonist timolol 
pg in 0.25 ~1 artificial CSF/min for 20 min) into VMH on plasma 
VMH LHA 
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and E concentrations before, during, and after exercise. In control 
experiment artificial CSF only was infused into VMH. Data are ex- 
pressed and definitions are as in Fig. 1. 
min was performed in experiment IIa (VMH) and exper- 
iment 1.b (LHA). In the control experiments aCSF was 
infused into the VMH or LHA at a rate of 0.25 pl/min 
for 20 min. The different experiments were performed in 
random order with at least 3 days in between subsequent 
experiments. 
Data were expressed as average ‘changes t SE from 
the basal values at t = -1 min in the home cage. Wilcoxon 
matched-pairs signed-rank test was used when the level 
of the blood components at a certain time during the 
experiment was compared with the basal value in the 
home cage. Two-way analysis of variance with repeated 
measures followed by a Mann-Whitney U test was ap- 
plied at each sample point to determine the significant 
differences between the experiment in which an adre- 
noceptor antagonist was administered and the control 
o-a PHEN 
o--o CSF 
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FIG. 3. Effect of infusion of a-adrenoceptor antagonist phentola- 
mine (1.05 pg in 0.25 ~1 artificial CSF/min for 20 min) into LHA on 
plasma NE and E concentrations before, during, and after exercise. In 
control experiment artificial CSF only was infused into LHA. Data are 
expressed and definitions are as in Fig. 1. 
experiment with aCSF. The criterion of significance was 
set at P C 0.05. 
RESULTS 
Table 1 presents the basal E, NE, and corticosterone 
levels in all experiments. There were no initial differ- 
ences between the groups. Figure 1 presents the changes 
from basal values in plasma E and NE concentrations 
after administration of phentolamine or aCSF into the 
VMH (experiment la). Plasma concentrations of E were 
significantly lower after phentolamine infusion in com- 
parison with the values in the control experiment at t = 
1, 5, 10, and 19 min during and after exercise. Plasma 
NE concentrations were not affected by VMH cu-block- 
ade. In Fig. 2 the effects of infusion of timolol or aCSF 
into the VMH (experiment Ib) on plasma E and NE 
concentrations are depicted. Infusion of timolol into the 
VMH increased plasma E (significant at t = 10 and 15 
min) and reduced plasma NE (significant at t = 1 and 
15 min) compared with the control experiment with 
aCSF. 
Infusion of phentolamine into the LHA (experiment 
IIa, Fig. 3) led to an increase in plasma NE concentra- 
tions (significant at t = 15, 19, 24, 29, and 39 min) in 




















0 - - -&z.L-F).. -.Q--&:+.+ - - - - ........ ...... ....... ...... ....... ...... ....... ...... ....... ...... ....... ...... ....... ...... ...... , I I I I 
0 20 0 15 min 
FIG. 4. Effect of infusion of the P-adrenoceptor antagonist timolol 
(0.7 pg in 0.25 ~1 artificial CSF/min for 20 min) into LHA on plasma 
NE and E concentrations before, during, and after exercise. In control 
experiment artificial CSF only was infused in LHA. Data are expressed 
and definitions are as in Fig. 1. 
remained unchanged after infusion of phentolamine in 
the LHA. Infusion of timolol into the LHA (experiment 
Ilb, Fig. 4) caused a significant increase in plasma E 
levels at t = 10,15, and 29 min compared with the control 
experiment with aCSF. Although plasma NE tended to 
be lower, no significant differences in plasma NE con- 
centrations occurred after infusion of timolol or aCSF in 
the LHA. Plasma corticosterone concentrations gradu- 
ally increased before and during exercise. 
Infusion of either phentolamine or timolol into either 
VMH or LHA did not significantly change& the plasma 
corticosterone levels from control values (Fig. 5). Exer- 
cise performance was not influenced by the hypothalamic 
infusion of the adrenoceptor antagonists or aCSF. 
DISCUSSION 
In rats, E is released by the adrenal medulla (20, 35) 
and affects glucose and insulin but not FFA concentra- 
tions in plasma (22). NE in plasma originates from the 
peripheral nerve endings of the sympathetic nervous 
system and acts in two different ways, as neurotransmit- 
ter via a-adrenoceptors in liver and pancreas and as a 
hormone on ,&adrenergic FFA release in adipose tissue 
(20, 21). Recently, we obtained evidence for an involve- 
ment of the central nervous system and, in particular, 
the hypothalamus in the regulation of glucose production 
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infusion of ar-adrenoceptor antagonist phentola- 
mine (1.05 pg in 0.25 ~1 artificial CSF/min for 20 min) or ,&adrenocep- 
tor antagonist timolol (0.7 pg in 0.25 ~1 artificial CSF/min for 20 min) 
into either VMH or the lateral hypothalamic area (LHA) on plasma 
corticosterone (tort) concentrations before, during, and after exercise 
(M). Control experiments with infusion of aCSF into VMH or LHA 
are depicted as O----O. Data are expressed and definitions are as in 
Fig. 1. 
amine release from the sympathoadrenal system (37). 
Blockade of the VMH with the anesthetic bupivacaine 
(Marcain) led to an impairment of the exercise-induced 
increases in both hepatic glucose production and blood 
glucose levels, as well as the plasma concentrations of 
NE and E (37). Hypothalamic influences on peripheral 
energy metabolism were principally mediated via cate- 
cholamine-sensitive neurons within the hypothalamus 
(10, 24, 27). Infusion of CU- and ,&adrenoceptor antago- 
nists into both VMH and LHA caused a marked reduc- 
tion in the exercise-induced increase in blood glucose 
levels, whereas a-adrenoceptor blockade restricted to the 
VMH stimulated FFA release, and P-adrenoceptor block- 
ade in both VMH and LHA inhibited FFA release (19). 
In the present study, a reduction in the exercise- 
induced increase of plasma E was found after cu-adreno- 
ceptor blockade of the VMH. Together with the data 
above, this suggests that, during exercise, an a-adreno- 
ceptor-mediated mechanism within the VMH may stim- 
ulate the release of E from the adrenal medulla, leading 
to an increase in hepatic glucose production and there- 
fore to increased blood glucose levels. Catecholamine 
infusions into the VMH of nonexercising animals showed 
that only NE and not E can cause an increase in blood 
glucose levels (27), indicating that the VMH a-adre- 
noceptors are probably activated by neuronal NE. The 
VMH is, however, not directly innervated by noradre- 
nergic nerve terminals, although a rich noradrenergic 
innervation occurs in a shell just around the VMH (29). 
It may be argued that the a-adrenoceptors, abundantly 
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put from the liver by influencing the release of adrenal 
E, are stimulated by NE released by the noradrenergic 
nerve endings in the shell around the nucleus. 
Blockade of VMH ,&adrenoceptors led to an immedi- 
ate decline in the exercise-induced increase in plasma 
NE. Infusion of timolol into the VMH also caused an 
immediate decrease in blood glucose concentrations in a 
previous study (19). The concomitant decrease in plasma 
NE and blood glucose after VMH ,&blockade is in ac- 
cordance with the findings of Matshushita and Shimazu 
(10, 24), who showed that a ,&adrenoceptor mechanism 
in the VMH is involved in the regulation of hepatic 
glucose production via an influence on peripheral sym- 
pathetic nerve activity. Plasma E concentrations signif- 
icantly increased above control levels in the last phase 
of exercise after VMH ,&adrenoceptor blockade. Blood 
glucose increased to moderately enhanced levels at those 
time points (19). This suggests that the increase in E 
release from the adrenal medulla in the last phase of 
exercise can be considered a contraregulatory mechanism 
triggered by the fall in blood glucose after VMH ,& 
blockade. 
The release of FFA from adipose tissue is predomi- 
nantly affected by circulating NE but not E (21). The 
relative reduction in plasma FFA concentrations after 
VMH ,&blockade as found formerly (19) can therefore 
easily be explained by reduced outflow of NE from the 
sympathetic nervous system. The enormous increase in 
plasma FFA after VMH a-blockade (19), however, seems 
inconsistent with the present changes in plasma NE 
concentrations. Maybe other humoral factors are in- 
volved, because the pituitary, which releases powerful 
factors such as lipotropins, is also under influence of the 
hypothalamus (9). 
Blockade of a-adrenoceptors in the LHA with phen- 
tolamine caused an enhancement of the exercise-induced 
increase in plasma NE concentrations without affecting 
plasma E levels. Infusion of the ,&adrenoceptor antago- 
nist timolol into the LHA increased plasma E concentra- 
tions above control levels and had no significant effect 
on plasma NE concentrations. Attention has to be paid 
to the effect of infusion of aCSF into the LHA on plasma 
catecholamines as found in the present study. Both 
plasma E and NE concentrations appeared to be mark- 
edly lower than in any other control experiment, whereas 
changes in NE and E after aCSF infusion into the VMH 
were highly replicable with all other comparable control 
experiments in swimming rats (20, 22). In a previous 
study with resting animals, comparable inconsistent ef- 
fects on plasma FFA levels were found after saline infu- 
sion into the LHA (27). This made us change the com- 
position of dilution solvent in later experiments, which 
indeed corrected for iatrogenic alterations in plasma FFA 
levels. It might be argued that the flow of fluid, an 
inadequate ionic composition, or a somewhat deviating 
pH of the corrected aCSF still caused some local neuronal 
changes in the LHA. 
The increased sympathetic activity after LHA cu-block- 
ade and the enhanced outflow of E from the adrenal 
medulla after LHA ,&blockade are completely inconsist- 
ent with the reported changes in blood glucose and 
plasma FFA concentrations after adrenoceptor blockade 
in the LHA during exercise (19). Similar alterations in 
plasma levels of glucose and FFA and their regulating 
hormones appeared after stimulation of hypothalamic 
adrenoceptors in unanesthetized nonexercising rats (27, 
34). These data suggest that 1) the hypothalamic inter- 
ference in peripheral glucose metabolism is not mediated 
via activation of the sympathoadrenal system, or 2) that 
catecholamine concentrations in venous blood are not 
always reliable as marker for sympathoadrenal activity. 
The first suggestion implies that changes in blood 
glucose and plasma FFA after hypothalamic adrenocep- 
tor manipulations are caused by the alterations in other 
gluco- and liporegulatory hormones than catechol- 
amines. Insulin from the ,&cells of the pancreas can be 
excluded as a possible factor, because plasma insulin 
concentrations were hardly affected by hypothalamic or 
,&adrenoceptor blockade (19). Plasma levels of glucagon, 
lipotropin, and growth hormone were not measured in 
these experiments. It seems unlikely, however, that the 
results can be explained by changes in these secondary 
glucose and FFA-regulating hormones from the pituitary 
or the endocrine pancreas. 
The second possibility challenges the generally ac- 
cepted idea that a uniform increase in sympathetic activ- 
ity occurs during exercise, and, as a consequence, that 
plasma NE levels may be used as a reliable index for 
sympathetic activation. Recent studies, however, have 
indicated that different patterns of activity may occur 
within the sympathetic nervous system (4,18,23). Selec- 
tive activation of the sympathetically innervated tissues 
may therefore not be excluded. Because sympathetic 
outflow of NE to the blood circulation is not uniform 
(the liver even extracts NE from the blood) (3, 6), this 
would indicate that plasma NE levels can be elevated 
during a selective inhibition of the sympathetic outflow 
to the liver. This means that the alterations in plasma 
norepinephrine concentrations in the present study do 
not necessarily argue against the proposed influence of 
catecholamine-sensitive neurons on sympathetic activa- 
tion of the liver, 
The distinctive alterations in NE and E concentrations 
after, for example, ,&adrenoceptor blockade in the VMH 
reinforce the idea that under specific conditions the 
outflow of NE from the peripheral nerve endings of the 
sympathetic nervous system can be dissociated from the 
release of E from the adrenal medulla (2, 20, 22, 40). 
Adrenoceptors in the VMH and LHA seem to be involved 
in the control of this selective activation of the two parts 
of the sympathoadrenal system. This hypothalamic 
mechanism may be considered another level of organi- 
zation in the sympathetic nervous system regulating 
sympathetic output during exercise. 
The results of the present study show that blockade of 
adrenergic receptors within specific areas in the hypo- 
thalamus markedly influences the activity of the periph- 
eral sympathoadrenal system during exercise. Physiolog- 
ical and neuroanatomic data (9,11,12) suggest that these 
hypothalamic adrenoceptors are principally influenced 
by NE-containing neurons in the central nervous system. 
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the Al and A2 cell groups in the brain stem and project- 16. 
ing on several areas in the hypothalamus through the 
ventral noradrenergic bundle, seems to play a role in the 17 
l 
REMIE, R., AND J. ZAAGSMA. A new technique for the study of 
vascular presynaptic receptors in freely moving rats. Am. J. Phys- 
iol. 251 (Heart Circ. Physiol. 20): H463-H467, 1986. 
activation of the hypothalamic adrenoceptors (11, 19). 
Finally, the corticosterone measurements indicate that 
adrenoceptors in the LHA or VMH are not involved in ~3. 
the regulation of peripheral corticosterone output from 
the adrenal cortex. 
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